NCT02467400View on ClinicalTrials.gov

Dose Response and Receptor Selectivity of Beta-blocker Effects on Bone Metabolism

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

165

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

October 26, 2017

Study Completion Date

April 1, 2018

Conditions

Osteoporosis, Age-Related

Interventions

DRUG

Atenolol

beta blocker

DRUG

Nebivolol

beta blocker

DRUG

Propranolol

beta blocker

DRUG

placebo

placebo

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER